Effects of Extended Storage of Chlorhexidine Gluconate and Benzalkonium Chloride Solutions on the Viability of Burkholderia cenocepacia

Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, o...

Full description

Saved in:
Bibliographic Details
Published inJournal of microbiology and biotechnology Vol. 27; no. 12; pp. 2211 - 2220
Main Authors Ahn, Youngbeom, Kim, Jeong Myeong, Lee, Yong-Jin, LiPuma, John J., Hussong, David, Marasa, Bernard S., Cerniglia, Carl E.
Format Journal Article
LanguageEnglish
Published Korea (South) 한국미생물·생명공학회 28.12.2017
Subjects
Online AccessGet full text
ISSN1017-7825
1738-8872
DOI10.4014/jmb.1706.06034

Cover

Abstract Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a "safe use" period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2-10 μg/ml) and BZK (10-50 μg/ml) at sublethal concentrations on six strains of using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six strains with different inoculum sizes (10⁰ -10⁵ CFU/ml), their toxic effects were not changed for 28 days. strains in diluted CHX and BZK were detectable at concentrations up to 10² CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products.
AbstractList Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a “safe use” period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2-10 μg/ml) and BZK (10-50 μg/ml) at sublethal concentrations on six strains of Burkholderia cenocepacia using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on B. cenocepacia strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six B. cenocepacia strains with different inoculum sizes (100 -105 CFU/ml), their toxic effects were not changed for 28 days. B. cenocepacia strains in diluted CHX and BZK were detectable at concentrations up to 102 CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that B. cenocepacia strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products. KCI Citation Count: 0
Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a “safe use” period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2–10 μg/ml) and BZK (10–50 μg/ml) at sublethal concentrations on six strains of Burkholderia cenocepacia using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on B. cenocepacia strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six B. cenocepacia strains with different inoculum sizes (10 0 –10 5 CFU/ml), their toxic effects were not changed for 28 days. B. cenocepacia strains in diluted CHX and BZK were detectable at concentrations up to 10 2 CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that B. cenocepacia strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products.
Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia cepacia complex (BCC) contamination of pharmaceutical products could be due to the use of contaminated water in the manufacturing process, over-diluted antiseptic solutions in the product, and the use of outdated products, which in turn reduces the antimicrobial activity of CHX and BZK. To establish a "safe use" period following opening containers of CHX and BZK, we measured the antimicrobial effects of CHX (2-10 μg/ml) and BZK (10-50 μg/ml) at sublethal concentrations on six strains of using chemical and microbiological assays. CHX (2, 4, and 10 μg/ml) and BZK (10, 20, and 50 μg/ml) stored for 42 days at 23°C showed almost the same concentration and toxicity compared with freshly prepared CHX and BZK on strains. When 5 μg/ml CHX and 20 μg/ml BZK were spiked to six strains with different inoculum sizes (10⁰ -10⁵ CFU/ml), their toxic effects were not changed for 28 days. strains in diluted CHX and BZK were detectable at concentrations up to 10² CFU/ml after incubation for 28 days at 23°C. Although abiotic and biotic changes in the toxicity of both antiseptics were not observed, our results indicate that strains could remain viable in CHX and BZK for 28 days, which in turn, indicates the importance of control measures to monitor BCC contamination in pharmaceutical products.
Author LiPuma, John J.
Kim, Jeong Myeong
Marasa, Bernard S.
Lee, Yong-Jin
Hussong, David
Cerniglia, Carl E.
Ahn, Youngbeom
AuthorAffiliation 1 Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA
3 Department of Pediatrics & Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA
5 Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
2 Department of Biological Sciences, Albany State University, Albany, GA 31707, USA
4 ValSource, LLC., Downingtown, PA 19335, USA
AuthorAffiliation_xml – name: 5 Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
– name: 3 Department of Pediatrics & Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA
– name: 1 Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA
– name: 2 Department of Biological Sciences, Albany State University, Albany, GA 31707, USA
– name: 4 ValSource, LLC., Downingtown, PA 19335, USA
Author_xml – sequence: 1
  givenname: Youngbeom
  surname: Ahn
  fullname: Ahn, Youngbeom
– sequence: 2
  givenname: Jeong Myeong
  surname: Kim
  fullname: Kim, Jeong Myeong
– sequence: 3
  givenname: Yong-Jin
  surname: Lee
  fullname: Lee, Yong-Jin
– sequence: 4
  givenname: John J.
  surname: LiPuma
  fullname: LiPuma, John J.
– sequence: 5
  givenname: David
  surname: Hussong
  fullname: Hussong, David
– sequence: 6
  givenname: Bernard S.
  surname: Marasa
  fullname: Marasa, Bernard S.
– sequence: 7
  givenname: Carl E.
  surname: Cerniglia
  fullname: Cerniglia, Carl E.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29032643$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002301533$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kctuFDEQRS0URB6wZYm8ZdGDH-1-rFAyGkKkSEgksLWq7eqMMz32yO1GCT_Ab-OeIQiQWJXtuve4VPeUHPngkZDXnC1Kxst399tuwWtWLVjFZPmMnPBaNkXT1OIonxmvi7oR6picjuM9YxUXTfWCHIuWSVGV8oT8WPU9mjTS0NPVQ0Jv0dKbFCLc4fy2XA8hrvHBWeeRXg6TCR4SUvCWXqD_DsMmeDdtD0Jnkd6EYUou-Iz0NK2RfnXQucGlx5l3McXNOgwWowNq0AeDOzAOXpLnPQwjvvpVz8iXD6vb5cfi-tPl1fL8ujCyUakwpQAmK8WtrFC2HbQSS4AalFQKVW94l6-8RglSdIpVnW0bVYIVFjslKnlG3h64PvZ6Y5wO4Pb1LuhN1Oefb6-0EILLqsna9wftbuq2aPO0KcKgd9FtIT7unX93vFtnzjfNhWwF2__25k_Cb-vT_rOgPAhMDOMYsdfGJZjXl4Fu0JzpOWadY9ZzzHofc7Yt_rE9kf9j-Akgjq0P
CitedBy_id crossref_primary_10_1016_j_ijmmb_2021_12_003
crossref_primary_10_1007_s11356_022_21812_8
crossref_primary_10_15585_mmwr_mm7148a3
crossref_primary_10_1016_j_heliyon_2023_e23792
crossref_primary_10_1089_mdr_2022_0212
crossref_primary_10_3389_fbioe_2020_00630
crossref_primary_10_1186_s13756_021_01004_8
crossref_primary_10_1017_ice_2023_241
crossref_primary_10_1016_j_ajic_2020_04_025
crossref_primary_10_1016_j_ijmmb_2020_10_023
crossref_primary_10_1128_CMR_00139_19
crossref_primary_10_1016_j_jhin_2018_05_019
crossref_primary_10_7759_cureus_30566
crossref_primary_10_21055_0370_1069_2023_4_91_95
crossref_primary_10_3390_hygiene3020010
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
ACYCR
DOI 10.4014/jmb.1706.06034
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1738-8872
EndPage 2220
ExternalDocumentID oai_kci_go_kr_ARTI_2221368
PMC12392026
29032643
10_4014_jmb_1706_06034
Genre Journal Article
GrantInformation_xml – fundername: Intramural FDA HHS
  grantid: FD999999
GroupedDBID ---
29L
53G
5GY
9ZL
AAYXX
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
DIK
DU5
F5P
FRP
GX1
HZB
JDI
OK1
P2P
RPM
SDH
TR2
CGR
CUY
CVF
ECM
EIF
NPM
5PM
MZR
ZZE
ID FETCH-LOGICAL-c385t-c42a03651d36e39ba93e4aa7a5355e5fc1b4aa17e3a32b506bd9854ad2deb5263
ISSN 1017-7825
IngestDate Sun Mar 09 07:51:34 EDT 2025
Sat Aug 30 05:11:23 EDT 2025
Sun Aug 31 01:36:46 EDT 2025
Thu Apr 24 22:57:36 EDT 2025
Tue Jul 01 02:12:10 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords antiseptic
benzalkonium chloride
Burkholderia cenocepacia
Bactericidal effects
chlorhexidine gluconate
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c385t-c42a03651d36e39ba93e4aa7a5355e5fc1b4aa17e3a32b506bd9854ad2deb5263
PMID 29032643
PageCount 10
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_2221368
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12392026
pubmed_primary_29032643
crossref_citationtrail_10_4014_jmb_1706_06034
crossref_primary_10_4014_jmb_1706_06034
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20171228
PublicationDateYYYYMMDD 2017-12-28
PublicationDate_xml – month: 12
  year: 2017
  text: 20171228
  day: 28
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of microbiology and biotechnology
PublicationTitleAlternate J Microbiol Biotechnol
PublicationYear 2017
Publisher 한국미생물·생명공학회
Publisher_xml – name: 한국미생물·생명공학회
SSID ssj0061286
Score 2.244959
Snippet Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia...
Chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) formulations are frequently used as antiseptics in healthcare and consumer products. Burkholderia...
SourceID nrf
pubmedcentral
pubmed
crossref
SourceType Open Website
Open Access Repository
Index Database
Enrichment Source
StartPage 2211
SubjectTerms Anti-Infective Agents, Local - pharmacology
Benzalkonium Compounds - pharmacology
Burkholderia cenocepacia - drug effects
Burkholderia cenocepacia - physiology
Chlorhexidine - analogs & derivatives
Chlorhexidine - pharmacology
Microbial Viability - drug effects
생물학
Title Effects of Extended Storage of Chlorhexidine Gluconate and Benzalkonium Chloride Solutions on the Viability of Burkholderia cenocepacia
URI https://www.ncbi.nlm.nih.gov/pubmed/29032643
https://pubmed.ncbi.nlm.nih.gov/PMC12392026
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002301533
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Microbiology and Biotechnology, 2017, 27(12), , pp.2211-2220
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6ISReEHc6LrIQEg9VSmLHuTxuU2Er2rSHDY2nyE4cGnVNUdVK2_4AP44_xTlx4ibdJg1ecjm13STn8_Fn-_iYkI9cSc_N_chRUcgdPxO4zUucO7GUUPciD-p65W1xHByc-eNzcd7r_Wl5La2Waphe37qu5H-0CjLQK66S_QfN2kJBANegXziChuF4Lx2P1s4Yo3owG6NrL6QZCdifQGd8oi-LDKnkV3ROL4FaVvMFe7q8lhfADovVzCQsMj2wg2T1HMLge2HieFfz8HurxRRnq_DVBqkuoemDHnch7yC4s2IjyBNcL2-M5O9OKrtXWR2lzUcyTgFm_bbGzZCOrvC04Tz0A0TOuFj7FBUnq5ls_IsH42F7RANaSc-uEDdGGGXAXMxstzayEAwzGMSO5TZRBRqEsrYdZrUJ1_VtteLuRnsBnUsf24uZGmIYoaEbuPXQaicw90aDad0YoQOFJSSQP8H8SZV_izxgYWh8Bg6_NbQAmGS17ah9ORNBFPN_7v5_hyFtlYu8RY66jrstJnT6hDyuNUx3DR6fkp4un5GHZlPTq-fkd41KOs9pg0paoxJlHVRSi0oKCKFtVNIGldSiks5LCqikFpVYXhuVtIXKF-Tsy-h0_8Cpt_twUh6JpZP6TAKfEl7GA81jJWOufSlDKYATa5GnnoJbL9RccqaEG6gsjoQvM5ZpJVjAX5Ltcl7q14QKyfyIazf1cu1HQa6YYG6oGMJCB8rvE6f5xElax8LHLVkukttV2iefbPpfJgrMnSk_gMaSaVokGLgdzz_nyXSRQPf0MMEH4EHUJ6-MHm1hLHahH-XzPok6GrYJsLDuL2UxqaLBA_WMmcuCnXs_4xvyaF3t3pLt5WKl3wG1Xqr3FWTheHxy9BfkhdRD
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Extended+Storage+of+Chlorhexidine+Gluconate+and+Benzalkonium+Chloride+Solutions+on+the+Viability+of+Burkholderia+cenocepacia&rft.jtitle=Journal+of+microbiology+and+biotechnology&rft.au=Ahn%2C+Youngbeom&rft.au=Kim%2C+Jeong+Myeong&rft.au=Lee%2C+Yong-Jin&rft.au=LiPuma%2C+John+J.&rft.date=2017-12-28&rft.issn=1017-7825&rft.eissn=1738-8872&rft.volume=27&rft.issue=12&rft.spage=2211&rft.epage=2220&rft_id=info:doi/10.4014%2Fjmb.1706.06034&rft.externalDBID=n%2Fa&rft.externalDocID=10_4014_jmb_1706_06034
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1017-7825&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1017-7825&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1017-7825&client=summon